With the explosion in the exchange traded fund market, it was inevitable that we would get news that some ETFs were closing down. Following a recommendation and approval from their board of directors, Claymore filed with the SEC on Friday to close 11 of their 37 ETFs. See Zac Bissonnette's analysis of why he thinks total market index funds are the way to go.
There are two main questions skeptics have with all the ETFs on the market.
- How many U.S. large cap ETFs can there be?
- How many investors are interested in some of the minutiae ETFs that exist.
For example one of the funds that Claymore is closing is the Claymore/Clear Global Vaccine Index (AMEX: JNR). How many investors feel it necessary to have as part of their asset allocation, exposure to a global vaccine index? Have we heard investors pounding down the door asking for such an index?
I am a big believer in ETFs, and I think they will continue to grow and provide investors with a low-cost way to invest, and in many cases a more profitable way to invest as well. But as frequently happens, things go a bit too far. Look for Claymore's announcement to be the first of many as we get a bout of consolidation and closings in the ETF industry.
Aaron Katsman is the lead Portfolio Manager and Managing Director of America Israel Investment Associates, LLC. and Senior Editor of IsraelNewsletter.com. DISCLOSURE: Writer has no positions in any stock mentioned as of 2/3/08

.gif)

.gif)


